Usefulness of skin advanced glycation end products to predict coronary artery calcium score in patients with type 2 diabetes.
Alejandra PlanasOlga Simó-ServatJordi BañerasMónica SánchezEsther GarcíaÁngel M OrtizMarisol Ruiz-MeanaCristina HernándezIgnacio Ferreira-GonzálezRafael SimòPublished in: Acta diabetologica (2021)
Our finding suggests that SAF could be useful in selecting T2D patients in whom the screening for CAD by means of CACs assessment would be more cost-effective.